Renaissance Technologies’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,599
| Closed | -$382K | – | 3563 |
|
|
2024
Q1 | $382K | Buy |
+5,599
| New | +$382K | ﹤0.01% | 2979 |
|
|
2023
Q4 | – | Sell |
-143,067
| Closed | -$6.49M | – | 3794 |
|
|
2023
Q3 | $6.49M | Sell |
143,067
-144,733
| -50% | -$6.57M | 0.01% | 1160 |
|
|
2023
Q2 | $16.2M | Sell |
287,800
-207,303
| -42% | -$11.6M | 0.02% | 774 |
|
|
2023
Q1 | $22.4M | Sell |
495,103
-291,497
| -37% | -$13.2M | 0.03% | 658 |
|
|
2022
Q4 | $32M | Buy |
786,600
+193,300
| +33% | +$7.86M | 0.04% | 500 |
|
|
2022
Q3 | $38.8M | Buy |
593,300
+24,600
| +4% | +$1.61M | 0.05% | 399 |
|
|
2022
Q2 | $34.6M | Sell |
568,700
-133,600
| -19% | -$8.12M | 0.04% | 481 |
|
|
2022
Q1 | $44.1M | Buy |
702,300
+123,458
| +21% | +$7.75M | 0.05% | 388 |
|
|
2021
Q4 | $43.9M | Buy |
+578,842
| New | +$43.9M | 0.05% | 374 |
|
|
2021
Q2 | – | Sell |
-123,110
| Closed | -$15M | – | 3501 |
|
|
2021
Q1 | $15M | Sell |
123,110
-30,090
| -20% | -$3.67M | 0.02% | 944 |
|
|
2020
Q4 | $23.5M | Sell |
153,200
-241,500
| -61% | -$37M | 0.03% | 677 |
|
|
2020
Q3 | $33M | Buy |
394,700
+26,042
| +7% | +$2.18M | 0.03% | 520 |
|
|
2020
Q2 | $27.1M | Sell |
368,658
-140,517
| -28% | -$10.3M | 0.02% | 661 |
|
|
2020
Q1 | $21.6M | Buy |
509,175
+114,611
| +29% | +$4.86M | 0.02% | 728 |
|
|
2019
Q4 | $24M | Buy |
394,564
+355,264
| +904% | +$21.6M | 0.02% | 911 |
|
|
2019
Q3 | $1.61M | Buy |
+39,300
| New | +$1.61M | ﹤0.01% | 2387 |
|
|
2019
Q1 | – | Sell |
-11,400
| Closed | -$326K | – | 3478 |
|
|
2018
Q4 | $326K | Buy |
+11,400
| New | +$326K | ﹤0.01% | 2999 |
|
|
2018
Q3 | – | Sell |
-171,100
| Closed | -$10.1M | – | 3370 |
|
|
2018
Q2 | $10.1M | Buy |
+171,100
| New | +$10.1M | 0.01% | 1346 |
|